Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

PAM-A INJECTION 500 mg/ampoule - HSA Drug Approval Details

Approvals/HSA/PAM-A INJECTION 500 mg/ampoule

Approved

THERAPEUTIC

PAM-A INJECTION 500 mg/ampoule

ILDONG PHARMACEUTICAL CO., LTD🇸🇬 Health Sciences Authority

Approval Date: Feb 18, 1991
Approval ID: 1c3e60b766fb29f0
Company: ILDONG PHARMACEUTICAL CO., LTD
Type: Therapeutic

Approval Details

Approval Id: 1c3e60b766fb29f0
Drug Name: PAM-A INJECTION 500 mg/ampoule
Product Name: PAM-A INJECTION 500 mg/ampoule
Approval Number: SIN05412P
Approval Date: 1991-02-18
Registrant: SHOEI UNIVERSAL CORPORATION PTE LTD
Licence Holder: SHOEI UNIVERSAL CORPORATION PTE LTD
Drug Type: Therapeutic
Forensic Classification: Prescription Only
Dosage Form: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Route Of Administration: INTRAVENOUS
Atc Code: V03AB04
Atc Item Name: pralidoxime
Pharma Manufacturer Name: SHOEI UNIVERSAL CORPORATION PTE LTD
Company Detail Path: /organization/shoei-universal-corporation-pte-ltd

Active Ingredients

PRALIDOXIME CHLORIDE

500 mg/ampoule

PRALIDOXIME CHLORIDE

500 mg/ampoule

Approved

Quick Info

Agency

HSA

Country

🇸🇬

Approval Date

Feb 18, 1991

Approval ID

1c3e60b766fb29f0

Type

Therapeutic

Back to HSA Approvals